DLDawn Song Yi Lin

Dawn Song Yi Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dawn Song Yi Lin has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • New approach methodologies in pharmaceutical development: Survey insights on adoption, infrastructure, and the path to broader implementation

    by Jessica C. Graham, Brandy Morenko, Damodaran Annamalai, Fatima Arjmand, Monika Burns, Danielle Elbirt, Brianna N. Gaskill, Moran Grossman, Dawn S.Y. Lin, Kathy Orsted, et al.

  • Open Access

    Automating Vascular Biology: An End‐to‐End Automated Workflow for High‐Throughput Blood Vessel‐on‐a‐Chip Production and Multi‐Site Validation

    by Dawn S. Y. Lin, Hanieh Mohammad Hashemi, Kimia Asadi Jozani, Anushree Chakravarty, Sonya Kouthouridis, Jessica Bonanno, Nicky Anvari, Shravanthi Rajasekar, Feng Zhang, Richard Y. Cheng, et al.

    There is a growing demand for automated organ‐on‐a‐chip platforms that are compatible with off‐the‐shelf robotic liquid‐handling systems and plate readers to improve reproducibility and scalable analysis. In this work, we present an end‐to‐end automated method for fabricating tubular blood vessel models at scale using a custom 384‐well open‐top platform (AngioPlate384), designed to support integration with liquid‐handling systems and large‐scale analysis. Our approach enables the generation of over 100 perfusable blood vessels fully embedded in hydrogel and supported by stromal cells (fibroblasts and pericytes), allowing both luminal and interstitial flow. Using this platform, we demonstrated that stromal co‐culture significantly enhances vascular barrier function, and results in an altered response to chemotherapeutics and to inflammatory stressors. This platform offers a robust and scalable approach to generating customizable blood vessel‐on‐a‐chip models for vascular biology studies, disease modeling, and preclinical testing. Its compatibility with automation and standardized workflows positions it as a powerful tool to accelerate the adoption of microphysiological systems in pharmaceutical research.


  • From Model System to Therapy: Scalable Production of Perfusable Vascularized Liver Spheroids in “Open-Top“ 384-Well Plate

    by Dawn S. Y. Lin, Shravanthi Rajasekar, Mandeep Kaur Marway, Boyang Zhang

    Vasculature is a key component of many biological tissues and helps to regulate a wide range of biological processes. Modeling vascular networks or the vascular interface in organ-on-a-chip systems is an essential aspect of this technology. In many organ-on-a-chip devices, however, the engineered vasculatures are usually designed to be encapsulated inside closed microfluidic channels, making it difficult to physically access or extract the tissues for downstream applications and analysis. One unexploited benefit of tissue extraction is the potential of vascularizing, perfusing, and maturing the tissue in well-controlled, organ-on-a-chip microenvironments and then subsequently extracting that product for in vivo therapeutic implantation. Moreover, for both modeling and therapeutic applications, the scalability of the tissue production process is important. Here we demonstrate the scalable production of perfusable and extractable vascularized tissues in an “open-top“ 384-well plate (referred to as IFlowPlate), showing that this system could be used to examine nanoparticle delivery to targeted tissues through the microvascular network and to model vascular angiogenesis. Furthermore, tissue spheroids, such as hepatic spheroids, can be vascularized in a scalable manner and then subsequently extracted for in vivo implantation. This simple multiple-well plate platform could not only improve the experimental throughputs of organ-on-a-chip systems but could potentially help expand the application of model systems to regenerative therapy.


  • Modeling organ-specific vasculature with organ-on-a-chip devices

    by Dawn Song Yi Lin, Feng Guo, Boyang Zhang

    Organ-on-a-chip devices, also known as microphysiological systems, have gained significant attention in recent years. Recent advances in tissue engineering and microfabrication have enabled these devices to provide more precise control over cellular microenvironments to mimic the tissue-level or organ-level function of the human body. These more complex tissue models can provide either an improvement in the functional expression and maturation of cells or an avenue to probe biological events and function that would otherwise be difficult to visualize and mechanistically study. This high-value information, when complimented with the existing gold-standards of cell-based assays and animal models, could potentially lead to more informed decision-making in drug development. A prevalent biological component in many organ-on-a-chip devices is an engineered vascular interface that is present in almost all organs of the human body. The vasculature and the vascular interface are particularly susceptible to biomechanical forces, they function as the conduits for inter-cellular and inter-organ interactions, and regulate drug transport. In this review, we examine the various approaches taken to model the human vasculature with an emphasis on the engineering of organ-specific vasculatures, and discuss various challenges and opportunities ahead as the field advances.